Irritable Bowel Syndrome (IBS) Clinical Trials

A clinical trial is currently being conducted to assess the safety and efficacy of a treatment for IBS-C.  

If you've tried Imodium and are still experiencing symptoms of abdominal pain and diarrhea, learn how you could be eligible to participate in a research study of an approved drug for Irritable Bowel Syndrome with diarrhea (IBS-D).

Seeking research volunteers for a clinical study of irritable bowel syndrome (IBS).

A 26-Week, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Tenapanor (study medication) for the Treatment of Constipation-Predominant Irritable Bowel Syndrome (IBS-C).

During the 12-week treatment period, subjects will record daily assessments including: frequency and timing of bowel movements; sensation and complete bowel emptying; consistency of bowel movements; degree of straining, worst abdominal pain, abdominal discomfort, abdominal bloating, abdominal fullness and abdominal cramping. Subjects will also record weekly assessments including: adequate relief ...

Men or women 18-75 years of age Abdominal discomfort Constipation Up to $600 for time and travel

A 12-week research study to test the safety and effectiveness of an investigational medication for the treatment of Irritable Bowel Syndrome with Constipation.

HWC Women's Research Center is conducting a 12 week clinical research study of an investigational medication for IBS-C. You may qualify for: Investigational Medication Study-related labs and care Reimbursement for time and travel

SP304203-04 : Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IIBS-C).

A Randomized, 12-Week, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Plecanatide in Patients with Irritable Bowel Syndrome with Constipation (IBS-C)